Pedemy

Study guide · Oncology

Pediatric chemotherapy toxicities: cisplatin, vincristine, asparaginase

Most chemotherapy drugs are tested by their signature organ toxicity. Learn the one-line pairs first, then the specific rescues and precautions that prevent harm.

For medical students, residents, nurses and pediatricians. Written from current guidelines; trees are from Pedemy's flashcards.

Main decision tree

Chemotherapy: asparaginase, vincas, topo, heart and lungs

Decision tree: Chemotherapy: asparaginase, vincas, topo, heart and lungs
From Pedemy's flashcards. Tap to open full size; explained in “Signature toxicities at a glance” below.

Key points

  • Signature toxicities: cisplatin → kidney and ears; vincristine → nerves and bowel; doxorubicin → heart; bleomycin → lungs.
  • Cyclophosphamide and ifosfamide cause hemorrhagic cystitis; mesna and hydration protect the bladder.
  • Cisplatin causes more nephrotoxicity and hearing loss than carboplatin.
  • Vincristine and vinblastine are IV only: intrathecal vinca alkaloid is fatal.
  • Vincristine: constipation that can progress to ileus, peripheral neuropathy, and SIADH with hyponatremia.
  • Asparaginase: hypersensitivity, pancreatitis, thrombosis and bleeding, hyperglycemia and liver injury.
  • High-dose methotrexate is followed by leucovorin rescue timed to methotrexate levels.

Signature toxicities at a glance

DrugMain toxicity to remember
CisplatinKidney injury with magnesium wasting, hearing loss
VincristineNeuropathy, constipation and ileus, SIADH
Doxorubicin and other anthracyclinesCardiomyopathy
BleomycinPneumonitis and pulmonary fibrosis
Cyclophosphamide, ifosfamideHemorrhagic cystitis
AsparaginaseAllergy, pancreatitis, clots and bleeding
Mercaptopurine, thioguanineMyelosuppression, liver toxicity
Methotrexate (high dose)Kidney injury, mucositis, marrow suppression

Cyclophosphamide, ifosfamide and mesna

Decision tree: Chemotherapy: alkylators and platinum
Chemotherapy: alkylators and platinum · from Pedemy's flashcards. Tap to open full size.

Cyclophosphamide and ifosfamide produce acrolein, a urinary metabolite that injures the bladder lining and causes hemorrhagic cystitis. Hydration and mesna, which binds acrolein in the urine, protect the bladder. Mesna protects only the bladder.

Blood on a urine dipstick during these drugs needs a urinalysis and a call to the oncology team. Ifosfamide can also cause encephalopathy and proximal tubular injury with Fanconi-type electrolyte wasting.

Cisplatin and carboplatin

Decision tree: Chemotherapy: platinum agents
Chemotherapy: platinum agents · from Pedemy's flashcards. Tap to open full size.
  • Cisplatin: kidney injury with magnesium and other electrolyte wasting, high-frequency hearing loss and delayed vomiting.
  • Cisplatin causes more nephrotoxicity and ototoxicity than carboplatin.
  • Carboplatin is dosed by kidney function and causes more marrow suppression.
  • Children on cisplatin need hearing tests and close electrolyte checks.

Anthracyclines and bleomycin

Decision tree: Chemotherapy: heart and lungs
Chemotherapy: heart and lungs · from Pedemy's flashcards. Tap to open full size.

Anthracyclines (doxorubicin, daunorubicin, idarubicin) and the related drug mitoxantrone cause dose-related cardiomyopathy, which can appear years after treatment. Survivors need lifelong echocardiogram surveillance based on cumulative dose and chest radiation. Doxorubicin turns urine red; mitoxantrone turns it blue-green.

Bleomycin causes pneumonitis that can progress to pulmonary fibrosis. A new dry cough or shortness of breath after bleomycin needs evaluation for this toxicity.

Vincristine and vinblastine

Decision tree: Chemotherapy: vinca alkaloids
Chemotherapy: vinca alkaloids · from Pedemy's flashcards. Tap to open full size.
  • IV only: intrathecal vincristine or vinblastine is a fatal route error.
  • Constipation is common and can progress to ileus: prevent it actively with a bowel regimen.
  • Peripheral neuropathy: jaw pain, foot drop, loss of reflexes.
  • SIADH with hyponatremia.
  • Vinblastine causes more marrow suppression than vincristine.

Asparaginase

Decision tree: Chemotherapy: asparaginase
Chemotherapy: asparaginase · from Pedemy's flashcards. Tap to open full size.

Asparaginase depletes circulating asparagine. Leukemic lymphoblasts cannot make enough of their own, so their protein synthesis fails. It is a core drug for acute lymphoblastic leukemia (ALL).

  • Hypersensitivity, including anaphylaxis, during or after a dose: watch closely during administration.
  • Pancreatitis: severe abdominal pain or vomiting after pegaspargase needs lipase and imaging.
  • Both thrombosis and bleeding: it lowers synthesis of both procoagulant and anticoagulant proteins.
  • Hyperglycemia and liver toxicity; low albumin and high triglycerides can also occur.
  • Asparaginase products are not interchangeable dose for dose.

Methotrexate, mercaptopurine and thioguanine

Decision tree: Chemotherapy: antimetabolites
Chemotherapy: antimetabolites · from Pedemy's flashcards. Tap to open full size.

After high-dose methotrexate, leucovorin (folinic acid) rescues normal cells. It is given on a schedule set by the time since the infusion and the methotrexate levels. Fluids and alkaline urine prevent methotrexate crystals in the kidney; a rising creatinine means slow clearance and needs urgent review, and glucarpidase is used for severe toxicity.

Mercaptopurine (6-MP) and thioguanine cause myelosuppression and liver toxicity. Allopurinol raises 6-MP levels, so the 6-MP dose must be cut sharply if both are given.

Common questions

Which chemotherapy drugs cause hemorrhagic cystitis?

Cyclophosphamide and ifosfamide. Hydration and mesna protect the bladder.

Why is leucovorin given after methotrexate?

Leucovorin supplies reduced folate to normal cells, rescuing them from high-dose methotrexate. Timing and dose follow methotrexate levels.

Why must vincristine never be given intrathecally?

Intrathecal vincristine causes ascending paralysis and is almost always fatal. Vinca alkaloids are for IV use only.

Study this topic

Sources

Written for Pedemy in our own words from the sources above; checked November 2026. For education only, not medical advice; check doses and local protocols before treating a patient. Pedemy is independent and not affiliated with or endorsed by the organizations cited.

All study guides by board exam domain →